Publications by authors named "Chise Ha"
Aims: To investigate the prevalence, treatment status, and effect of anemia on medical costs, quality of life (QOL), and productivity loss in Japan.
Methods: This cross-sectional study used a database containing claims, health check-ups, and questionnaire data. Adults with hemoglobin data at 2020 check-ups were included.
Article Synopsis
- The study aimed to explore the preferences of the Japanese public regarding government policies to manage infectious disease outbreaks.
- A survey, using conjoint analysis with 2,185 respondents, found that accessibility to therapeutic drugs, tests, and vaccines was highly valued, with drug accessibility having the highest estimated monetary value of JPY 10.5 trillion.
- The findings indicated a clear preference for accessibility of medical resources over behavioral or entry restrictions during the ongoing COVID-19 pandemic, although the sample may not fully represent the broader population.
Introduction: During the recent coronavirus disease 2019 (COVID-19) pandemic, preferences for factors associated with vaccines have been evaluated. Three oral antiviral drugs have been approved in Japan for patients with mild-to-moderate I COVID-19 symptoms. Although preferences for the drugs may also depend on various factors, these have not been fully evaluated.
View Article and Find Full Text PDFAims: This study aimed to estimate the utility values of the factors associated with intravenous (IV) iron infusion treatment in Japanese patients with iron-deficiency anemia (IDA) from the patient's perspective.
Methods: A conjoint analysis based on online survey data was conducted in May 2022 (registration number: UMIN000047756). Respondents in the main group were selected from the general population (20-69 years).